Lilly & Co Eli Avidity Biosciences, Inc. (RNA) insider trading activity

RNA Quotes by TradingView

Lilly & CO Eli is of Avidity Biosciences, Inc.. Currently has a direct ownership of 2.17 Million shares of RNA, which is worth approximately $91.5 Million. The most recent transaction as insider was on Jun 16, 2020, when has been sold 2,169,396 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.17M
0% 3M change
0% 12M change
Total Value Held $91.5 Million

LILLY & Co ELI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 16 2020
BUY
Conversion of derivative security
-
2,169,396 Added 50.0%
2,169,396 Common Stock

Also insider at

CLCD
CoLucid Pharmaceuticals, Inc.
> 10% Shareholder
ZYME
Zymeworks Inc. Healthcare
> 10% Shareholder
LPTX
LEAP THERAPEUTICS, INC. Healthcare
> 10% Shareholder
ELAN
Elanco Animal Health Inc Healthcare
> 10% Shareholder
SGTX
Sigilon Therapeutics, Inc. Healthcare
> 10% Shareholder
L&C

Lilly & CO Eli

Indianapolis, IN

Track Institutional and Insider Activities on RNA

Follow Avidity Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNA shares.

Notify only if

Insider Trading

Get notified when an Avidity Biosciences, Inc. insider buys or sells RNA shares.

Notify only if

News

Receive news related to Avidity Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RNA